A Study Evaluating the Safety, Pharmacokinetic and Anti-tumor Activity of RO7428731 in Participants With Glioblastoma
Clinical trial NCT05187624 · COMPLETED
Trial details
- NCT number
- NCT05187624
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-05
- Primary completion
- 2025-05-14
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.